SynthesisBMC pediatrics2025
Musculoskeletal manifestations of childhood malignancies: a systematic review and meta-analysis.
Synthesis in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical and Laboratory Indicators of Pediatric Leukemia and Neuroblastoma in Musculoskeletal Presentations: A Retrospective Study From a Resource-Limited Setting.European journal of haematology · 2026Article
- Differentiating Juvenile Idiopathic Arthritis From Acute Lymphoblastic Leukemia in Children: A Multidisciplinary Diagnostic Approach, Systematic Review and Meta-Analysis.Journal of clinical medicine research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTimely diagnosis of malignancies in children is very important. Knowing the clinical manifestations of malignancies help in timely diagnosis. The aim of this study is to investigate the prevalence of musculoskeletal manifestations of malignancies in children.
methodswe searched the manuscript databases including Scopus, Web of science, Google scholar, Medline, and Cochrane for all studies in accordance with the relevant keywords. The nine-star Newcastle-Ottawa Scale (NOS) scoring system was employed to assess the methodological quality of all eligible studies. Statistical analysis was performed using the Comprehensive Meta-Analysis (CMA) software.
resultsOf 96 articles initially collected by database searching, 13 articles were eligible for the final analysis. The major musculoskeletal manifestations related to childhood malignancies include bone pain, bone swelling, bone tenderness, bone fracture, vertebral collapses, joint effusion and joint tenderness. Manifestations related to these malignancies also include septic arthritis-type symptoms, osteomyelitis-type symptoms, and osteomyelitis. The overall pooled prevalence of musculoskeletal manifestations in children suffering hematopoietic tumors (acute lymphoblastic leukemia and acute myeloid leukemia) was 32.1% (95%CI: 24.0-41.3%). The overall prevalence of musculoskeletal manifestations due to neuroblastoma was also 30.5% (95%CI: 19.2-44.9%). The rate of musculoskeletal manifestations due to other childhood cancers range from 23.5 to 80.3%.
conclusionA significant part of childhood malignancies are associated with musculoskeletal manifestations. Clinicians should carefully evaluate and closely follow children with musculoskeletal manifestations to timely diagnosing of malignancies. TRIAL REGISTRATION NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.